Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?

David Palma¹, Megan Daly², James Urbanic³, Meredith Giuliani⁴

Affiliations

¹ Department of Radiation Oncology, London Health Sciences Centre, London, Canada. Electronic address: David.Palma@lhsc.on.ca.
² Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
³ Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California.
⁴ Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.

PMID: 30957741
DOI: 10.1016/j.ijrobp.2018.10.008

Comment

Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?

David Palma et al. Int J Radiat Oncol Biol Phys. 2019.

. 2019 Mar 15;103(4):788-791.

doi: 10.1016/j.ijrobp.2018.10.008. Epub 2019 Feb 20.

Authors

David Palma¹, Megan Daly², James Urbanic³, Meredith Giuliani⁴

Affiliations

¹ Department of Radiation Oncology, London Health Sciences Centre, London, Canada. Electronic address: David.Palma@lhsc.on.ca.
² Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
³ Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California.
⁴ Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.

PMID: 30957741
DOI: 10.1016/j.ijrobp.2018.10.008

No abstract available

PubMed Disclaimer

Comment on

Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer.
Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, Hashemi S, Nossent E, Spoelstra F, de Langen AJ, Slotman B, Senan S. Tekatli H, et al. J Thorac Oncol. 2016 Jul;11(7):1081-9. doi: 10.1016/j.jtho.2016.03.008. Epub 2016 Mar 21. J Thorac Oncol. 2016. PMID: 27013408
Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.
Horne ZD, Richman AH, Dohopolski MJ, Clump DA, Burton SA, Heron DE. Horne ZD, et al. Lung Cancer. 2018 Jan;115:1-4. doi: 10.1016/j.lungcan.2017.10.014. Epub 2017 Nov 10. Lung Cancer. 2018. PMID: 29290248
Ultracentral Tumors Treated With Stereotactic Body Radiotherapy: Single-Institution Experience.
Raman S, Yau V, Pineda S, Le LW, Lau A, Bezjak A, Cho BCJ, Sun A, Hope AJ, Giuliani M. Raman S, et al. Clin Lung Cancer. 2018 Sep;19(5):e803-e810. doi: 10.1016/j.cllc.2018.06.001. Epub 2018 Jun 18. Clin Lung Cancer. 2018. PMID: 30007498 Clinical Trial.
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H. Bezjak A, et al. J Clin Oncol. 2019 May 20;37(15):1316-1325. doi: 10.1200/JCO.18.00622. Epub 2019 Apr 3. J Clin Oncol. 2019. PMID: 30943123 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?

Affiliations

Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?

Authors

Affiliations

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical